A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.

Geoffrey L UyM P RettigR M StoneM Y KonoplevaM AndreeffK McFarlandW ShannonT R FletcherT ReineckW EadesKeith E Stockerl-GoldsteinC N AbboudM A JacobyP WesterveltJ F DiPersio

Published in: Blood cancer journal (2017)

Keyphrases

acute myeloid leukemia
open label
allogeneic hematopoietic stem cell transplantation
placebo controlled
double blind
cerebrospinal fluid
acute lymphoblastic leukemia
clinical trial
randomized controlled trial